Inventor · disambiguated record
Arnold Munnich
Also filed as: MUNNICH ARNOLD
12 granted patents·15 pending applications·171 citations·filing 1995–2023
90Inventor score
Files withINST NAT SANTE RECH MED12MUNNICH ARNOLD4MELKI JUDITH3BAYLOR COLLEGE MEDICINE1CORMIER-DAIRE VALERIE1
Top patents by PatentIndex Score
27 records- 0189US6824972B2Diagnosis and treatment of medical conditions associated with defective NFkappa B(NF-κB) activationBAYLOR COLLEGE MEDICINE·Filed 2001·Granted Nov 30, 2004·104 cites·13 claims
- 0284US2024350490A1Antagonist of the fibroblast growth factor receptor 3 (fgfr3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of fgfr3INST NAT SANTE RECH MED·Filed 2023·Application pending·0 cites
- 0382US9931341B2Antagonist of the fibroblast growth factor receptor 3 (FGFR3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of FGFR3INST NAT SANTE RECH MED·Filed 2015·Granted Apr 3, 2018·2 cites·1 claims
- 0481US11357778B2Antagonist of the fibroblast growth factor receptor 3 (FGFR3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of FGFR3INSTITUT NATIONAL DE LA SANTE ET DE LE RECH MEDICALE INSERM·Filed 2019·Granted Jun 14, 2022·2 cites·1 claims
- 0581US8962269B2Spinal muscular atrophy diagnostic methodsINST NAT SANTE RECH MED·Filed 2013·Granted Feb 24, 2015·2 cites·17 claims
- 0678US6080577ASurvival motor neuron (SMN) gene: a gene for spinal muscular atrophyINST NAT SANTE RECH MED·Filed 1995·Granted Jun 27, 2000·22 cites·8 claims
- 0777US7033752B1Spinal muscular atrophy diagnostic methodsINST NAT SANTE RECH MED·Filed 1998·Granted Apr 25, 2006·21 cites·22 claims
- 0876US8394932B2Survival motor neurons (SMN) gene: a gene for spinal muscular atrophyMELKI JUDITH·Filed 2011·Granted Mar 12, 2013·2 cites·6 claims
- 0974US2023075776A1Antagonist of the fibroblast growth factor receptor 3 (fgfr3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of fgfr3INST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
- 1072US2024117344A1Methods for performing antisense oligonucleotide-mediated exon skipping in the retina of a subject in need thereofINST NAT SANTE RECH MED·Filed 2023·Application pending·0 cites
- 1162US9834820B2Methods for the treatment and diagnosis of bone mineral density related diseasesINSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECH MEDICALE)·Filed 2014·Granted Dec 5, 2017·1 cites·2 claims
- 1261US11667913B2Methods for performing antisense oligonucleotide-mediated exon skipping in the retina of a subject in need thereofINST NAT SANTE RECH MED·Filed 2014·Granted Jun 6, 2023·0 cites·9 claims
- 1358US2018161327A1Antagonist of the fibroblast growth factor receptor 3 (fgfr3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of fgfr3NSTITUT NATIONAL DE LA SANTE ET DE LA RECH MEDICALE INSERM·Filed 2018·Application pending·0 cites
- 1458US2007166737A1Survival motor neuron (SMN) gene: a gene for spinal muscular atrophyMELKI JUDITH·Filed 2006·Application pending·0 cites
- 1557US11857532B2Treatment and prediction of therapeutic responses in patients suffering from Friedreich ataxiaINST NAT SANTE RECH MED·Filed 2019·Granted Jan 2, 2024·0 cites·12 claims
- 1654US2006089490A1Survival motor neuron (SMN) gene: a Gene for spinal muscular atrophyMELKI JUDITH·Filed 2005·Application pending·0 cites
- 1753US6040142AMethod and probes for detecting markers linked to the infantile spinal muscular atrophy locusINST NAT SANTA ET DE LA RECH M·Filed 1995·Granted Mar 21, 2000·15 cites·16 claims
- 1849US2010284991A1Methods for the Treatment and Diagnosis of Bone Mineral Density Related DiseasesINST NAT SANTE RECH MED·Filed 2008·Application pending·0 cites
- 1948US2009023784A1Use of deferiprone and methods to treat and/or prevent friedreich ataxia resulting from intracellular mishandling of ironMUNNICH ARNOLD·Filed 2007·Application pending·0 cites
- 2048US2007197649A1Use of deferiprone and methods to treat and/or prevent Friedreich Ataxia resulting from intracellular mishandling of ironMUNNICH ARNOLD·Filed 2007·Application pending·0 cites
- 2146US2012110684A1Method for Diagnosing or Predicting a Non Syndromic Autosomal Recessive Optic Atrophy, or a Risk of a Non Syndromic Autosomal Recessive Optic AtrophyROZET JEAN-MICHEL·Filed 2010·Application pending·0 cites
- 2245US2013190365A1Use of Deferiprone and Methods to Treat and/or Prevent Friedreich Ataxia Resulting from Intracellular Mishandling of IronMUNNICH ARNOLD·Filed 2013·Application pending·0 cites
- 2345US2016032382A1Method for Diagnosing or Predicting a Non Syndromic Autosomal Recessive Optic Atrophy, or a Risk of a Non Syndromic Autosomal Recessive Optic AtrophyINST NAT SANTE RECH MED·Filed 2015·Application pending·0 cites
- 2444US2015106960A1Method for diagnosing a skeletal ciliopathyINST NAT SANTE RECH MED·Filed 2013·Application pending·0 cites
- 2542US2016369348A1Methods for diagnosing and treating myhre syndromeCORMIER-DAIRE VALERIE·Filed 2016·Application pending·0 cites
- 2640US2014308275A1Methods for diagnosing and treating myhre syndromeCORMIER-DAIRE VALÉRIE·Filed 2012·Application pending·0 cites
- 2736US8097287B2Use of a Ginkgo biloba extract for the treatment of mitochondrial disease of genetic originMUNNICH ARNOLD·Filed 2007·Granted Jan 17, 2012·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Arnold Munnich files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →